These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31688453)

  • 1. Risk of Pathological Gambling and Impulse Control Disorders With Dopamine Agonists: A Retrospective Cohort Study.
    Sodhi M; Etminan M; Carleton B; Samii A
    J Clin Psychopharmacol; 2019; 39(6):675-676. PubMed ID: 31688453
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial dopamine agonist-induced pathological gambling and impulse-control deficit on low-dose aripiprazole.
    Peterson E; Forlano R
    Australas Psychiatry; 2017 Dec; 25(6):614-616. PubMed ID: 28696131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.
    Etminan M; Sodhi M; Samii A; Procyshyn RM; Guo M; Carleton BC
    J Clin Psychopharmacol; 2017 Feb; 37(1):102-104. PubMed ID: 27930495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review.
    Grall-Bronnec M; Sauvaget A; Perrouin F; Leboucher J; Etcheverrigaray F; Challet-Bouju G; Gaboriau L; Derkinderen P; Jolliet P; Victorri-Vigneau C
    J Clin Psychopharmacol; 2016 Feb; 36(1):63-70. PubMed ID: 26658263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole: impulse control disorders. Pathological gambling.
    Prescrire Int; 2016 Nov; 25(176):271. PubMed ID: 30730124
    [No Abstract]   [Full Text] [Related]  

  • 6. Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.
    Fusaroli M; Raschi E; Giunchi V; Menchetti M; Rimondini Giorgini R; De Ponti F; Poluzzi E
    Int J Neuropsychopharmacol; 2022 Sep; 25(9):727-736. PubMed ID: 35639870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk for developing gambling disorder under the treatment with pramipexole, ropinirole, and aripiprazole: A nationwide register study in Sweden.
    Wolfschlag M; Håkansson A
    PLoS One; 2021; 16(6):e0252516. PubMed ID: 34061895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia.
    Holman AJ
    J Gambl Stud; 2009 Sep; 25(3):425-31. PubMed ID: 19241148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole and impulse-control disorders in high-risk patients.
    Mohan T; Dolan S; Mohan R; Dawson J
    Asian J Psychiatr; 2017 Jun; 27():67-68. PubMed ID: 28558898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
    Dias Alves M; Micoulaud-Franchi JA; Simon N; Vion-Dury J
    J Clin Psychopharmacol; 2018 Dec; 38(6):555-562. PubMed ID: 30247179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole induced Impulse Control Disorders: Where do we stand?
    Mahapatra A; Sharma P; Sagar R
    Asian J Psychiatr; 2016 Oct; 23():128-130. PubMed ID: 27969070
    [No Abstract]   [Full Text] [Related]  

  • 13. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
    Moore TJ; Glenmullen J; Mattison DR
    JAMA Intern Med; 2014 Dec; 174(12):1930-3. PubMed ID: 25329919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics.
    Ng-Mak D; Messali A; Huang A; Wang L; Loebel A
    Am J Manag Care; 2019 Jul; 25(14 Suppl):S279-S286. PubMed ID: 31365818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list.
    Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E
    Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
    Bienfait KL; Menza M; Mark MH; Dobkin RD
    J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine agonist withdrawal syndrome (DAWS): perils of flicking the dopamine 'switch'.
    Edwards MJ
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):120. PubMed ID: 22993451
    [No Abstract]   [Full Text] [Related]  

  • 18. [Impulse control disorders associated with dopaminergic agonists in Parkinson's disease. Case report].
    Gamboa Arango A; Bernal Bernal MT; Duaso Magaña E
    Rev Esp Geriatr Gerontol; 2016; 51(5):304-5. PubMed ID: 27016028
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating prolactinomas with dopamine agonists: always worth the gamble?
    Noronha S; Stokes V; Karavitaki N; Grossman A
    Endocrine; 2016 Feb; 51(2):205-10. PubMed ID: 26336835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escalation of Gambling Associated With Aripiprazole: A Case Report and Literature Review.
    Giri YR; Peteru SR
    J Psychiatr Pract; 2019 Mar; 25(2):139-145. PubMed ID: 30849063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.